|« Previous month||Next month »|
27-Feb-2014 - European regulators have been accused of making “no attempt” to counter misuse of prescription drugs in comparison with North American efforts to reformulate and restrict addictive drugs, according to a...
27-Feb-2014 - Novartis says it will continue to spend around $1m a week on clinical trials in the UK after its R&D site closes in June.
27-Feb-2014 - BASF has hiked its prices for ethanolamines in Europe citing continuous demand increase.
27-Feb-2014 - National prioritization, investments in healthcare infrastructure and building better epidemiological and cost databases could bring more innovative medicines to middle-income countries, according to an independent study conducted by Charles River Associates. ...
27-Feb-2014 - Doctors, lawyers, State Department and World Bank spokesmen met on Wednesday to discuss the state of the Indian pharmaceutical world.
26-Feb-2014 - Fast-moving consumer goods industries and the financial world will be the next pools for sourcing pharmaceutical talent, says the CEO of pharmaceutical executive head-hunters RSA.
26-Feb-2014 - Failing to ensure data integrity at a control laboratory in India has landed drugmaker USV with a US FDA warning letter.
26-Feb-2014 - Pfizer says its hypothyroid drug Levoxyl will be available within a week after a musty smell coming from the oxygen-absorbing canister stopped production last February.
26-Feb-2014 - Pharma industry employees and wholesalers with access to narcotic APIs would be subject to background checks and drug testing under new proposals being considered in the US.
25-Feb-2014 - FMC has hired Connell Brothers (CBC) to distribute its drug excipients in Japan, citing the move as a key step to building its business in the country.
25-Feb-2014 - In a conference call Friday, FDA Commissioner Margaret Hamburg explained the importance of her recent trip to India, calling for more harmonization between the regulators.
25-Feb-2014 - The US FDA on Monday announced in a draft guidance that it’s revising its historical interpretation of the 5-year NCE exclusivity provisions to further incentivize the development of certain fixed-combination...
25-Feb-2014 - Ranbaxy has temporarily halted all shipments from two API plants currently under a US FDA consent decree, although both the firm and an analyst say a shortage is unlikely.
24-Feb-2014 - European politicians and industry have disagreed on new plans to ask pharmaceutical firms to pay fees for drug safety assessments.
24-Feb-2014 - Development of a new quality "super office" was motivated by a desire to simplify oversight and is not a response to the recent spate of problems at overseas suppliers, says...
24-Feb-2014 - Simon Sturge leaves Boehringer Ingelheim to head Merck's biosimilars unit, as well as the European Medicines Agency, Shire and EFPIA in this week's People on the Move column.
20-Feb-2014 - Four more drug excipient suppliers have been certified under the newly independent Excipact quality scheme.
20-Feb-2014 - The EMA has confirmed that new monthly drug safety discussions with US counterparts will focus on information exchange rather than policy development.
20-Feb-2014 - Fraudsters who try to extort money by impersonating regulators are an ongoing problem, the US FDA says, after the Gujarat FDCA warns drugmakers about a new scam.
20-Feb-2014 - A longer than expected upgrade to one of its injectable plants has caused Pfizer to announce that there is a shortage of methylprednisolone sodium succinate injections.
19-Feb-2014 - The European Commission (EC) has increased the pressure on Ireland, Italy, Poland and Slovenia to fall into line with other EU member States and introduce anti-drug counterfeiting legislation.
19-Feb-2014 - As Commisioner Margaret Hamburg flies back from an eight day tour of India, the US Food and Drug Administration (FDA) says it is recruiting seven new drug investigators in the...
19-Feb-2014 - The US FDA announced on Monday that it would initiate a Secure Supply Chain Pilot Program to enhance the security of imported drugs.
18-Feb-2014 - Debate rages over the significance of safety data from a trial of Oramed’s oral insulin pill, but the firm is still confident in its delivery technology.
|« Previous month||Next month »|